Technology Logistics directors take up cancer bike ride challenge

Running the most widely accredited mobile device repair facility in the UK is tough enough but four directors from Midlands-based Unipart Technology Logistics reckon it will seem like a stroll in the park compared to their latest challenge.


More at home in the boardroom than the saddle, Managing Director Claire Walters,

IT Director Steve Thomason, Operations Director Barrie Brackstone and Commercial

Director Nicola Couse will be donning their cycling shorts this September and

pedaling the 300 miles from London to Paris to raise money for Beating Bowel

Cancer, the UK's leading bowel cancer charity. Bowel cancer is the second biggest cancer killer in the UK after lung cancer, with 35,500 people diagnosed with the

disease every year.


The intrepid four are set to complete the route in just four days from 30 September to 3 October. The time and hard work that the team are committing to complete the

challenge will all be worthwhile if they succeed in reaching their target of £25,000 for a cause close to the hearts of the team, who have lost family, friends and colleagues to the disease.


"The last time I rode a bike there were stabilisers attached, and that was 25 years ago!" says Claire. "But now I'm cycling every day after work and am doing 70 miles every weekend.


"We're absolutely committed to completing the ride and raising the funds to ensure that Beating Bowel Cancer can continue to provide essential care to bowel cancer

sufferers and their families, as well as ongoing research and education."

UTL's suppliers and customers have already been generous with their donations, but the team still has a long way to go to achieve its target, so it's hoping that industry associates, acquaintances and friends will dig deep to sponsor the team if they can.Those wishing to contribute can donate using their credit or debit card on the team's online fundraising page at www.justgiving.com/utl_in_paris09. All money received goes directly to Beating Bowel Cancer.